News

1. Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development 5/29/2026
2. AGC Biologics Launches BravoAAV™ And ProntoLVV™ Platforms 5/18/2023

   The new Biologics AAV and LVV platforms offer fast, efficient, and reproducible clinical and commercial GMP production and release and are supported by proprietary process and capsid-specific platform methods.

3. Northway Biotech Enters Into Partnership Agreement With Revolo Biotherapeutics To Manufacture Revolo Biotherapeutics' Novel Binding Immunoglobulin Protein '1805 9/1/2021

   Northway Biotech, a global end-to-end biopharmaceutical CDMO announced that it has entered into a partnership with Revolo Biotherapeutics, a company developing therapies that reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, to manufacture Revolo Biotherapeutics' binding immuno-regulatory protein, ‘1805.

4. Nanoform's Final Clinical Results Confirm Value Proposition To The Pharma Industry 5/18/2021

   The clinical results show that Nanoform’s CESS® technology enabled development of a fast-acting piroxicam immediate release (IR) tablet formulation with more rapid absorption and improved drug delivery performance in comparison to a standard reference IR tablet.

5. Ajinomoto Co., Inc. And Bright Peak Therapeutics Inc. Enter Into A Research Collaboration And License Agreement To Create Novel Immunocytokines 3/29/2021

   Ajinomoto Co., Inc., a leading technology provider for biopharmaceuticals and the owner of Ajinomoto Bio-Pharma Services offering pharmaceutical contract development and manufacturing services, and Bright Peak Therapeutics Inc., a biotechnology company developing next generation immunotherapies for cancer and autoimmune disease, announced a research collaboration and exclusive license agreement to incorporate AJICAP^®, Ajinomoto Co.’s proprietary site-specific bioconjugation technology, for the development of Bright Peak Immunocytokines.

6. Sharp Invests $10M In Biologics And Injectables Packaging Equipment 10/12/2020

   Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has announced a further investment of $10M in equipment capabilities to directly support client demand in the biologics and injectables market.

7. Thermo Fisher Scientific To Double Its Capacity Of Viral Vector Manufacturing 5/15/2020

   To support increasing demand for viral vector development and manufacturing services, Thermo Fisher is expanding capacity with construction of a new commercial manufacturing site in Plainville, Mass. The 290,000-square-foot facility will more than double commercial viral vector capacity to support customers who are developing and manufacturing gene therapies and vaccines to address unmet medical needs.

8. Aesica Delivers Advanced QP Release Services Across Multiple Dosage Forms 8/12/2013

   Aesica Pharmaceuticals has established a new Quality Assurance team focused on delivering a range of QP services across oral, topical, inhalable and parenteral dosage forms in Investigational Medicinal Products (IMP) clinical trial release, combined with the capability to assess other alternative formats as well.

9. Pharmalink AB Receives Patent For Nefecon® Principle 10/26/2012

   Pharmalink AB announced today that it has been granted Japanese Patent No 4326696, "Methods and means for treating glomerulonephritis" for its product Nefecon(R) which is being developed to treat IgA nephropathy, a glomerulonephritis leading to end-stage renal disease (ESRD).

10. Fujifilm Diosynth Biotechnologies Announces Strategic Alliance With Piramal Healthcare For Production Of Antibody Drug Conjugates 10/24/2012

    Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs), a growing niche in the development of biopharmaceuticals.